Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Phosphoramidate derivatives of 5-fluoro-2′-deoxyuridine for use in the treatment of cancer

Phosphoramidate derivatives of 5-fluoro-2′-deoxyuridine for use in the treatment of cancer

US Patent 10022390 · Granted Jul 17, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

2′ and/or 5′ amino-acid ester phosphoramidate 3′-deoxy adenosine derivatives as 2024
Phosphoramidate derivatives of 5-fluoro-2′—deoxyuridine for use in the treatment2024
Phosphoramidate derivatives of 5-fluoro-2′—deoxyuridine for use in the treatment2024
Phosphoramidate derivatives of 5-fluoro-2′—deoxyuridine for use in the treatment2024
Phosphoramidate derivatives of 5-fluoro-2′—deoxyuridine for use in the treatment2024
Phosphoramidate derivatives of 5-fluoro-2′—deoxyuridine for use in the treatment2024
Gemcitabine prodrugs2023
Gemcitabine prodrugs2023
Phosphoramidate derivatives of 5-fluoro-2′-deoxyuridine for use in the treatment2023
Phosphoramidate derivatives of 5-fluoro-2′-deoxyuridine for use in the treatment2023
Phosphoramidate derivatives of 5-fluoro-2′-deoxyuridine for use in the treatment2023
Phosphoramidate derivatives of 5-fluoro-2′-deoxyuridine for use in the treatment2023